1Michael, MD, Kulkarni, RN, Postic, C, et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6, 87–97.
2de Marco, R, Locatelli, F, Zoppini, G, et al. (1999) Cause specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22, 756–761.
3Maritim, AC, Sanders, RA & Watkins, JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17, 24–38.
4Chiu, KC, Chu, A, Go, VL, et al. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820–825.
5Kumar, PT, Antony, S, Nandhu, MS, et al. (2010) Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats. J Nutr Biochem 22, 418–425.
6Kato, S, Yoshizazawa, T, Kitanaka, S, et al. (2002) Molecular genetics of vitamin D-dependent hereditary rickets. Horm Res 57, 73–78.
7Mee, AP, Davenport, LK, Hoyland, JA, et al. (1996) Novel and sensitive detection systems for the vitamin D receptor– in situ-reverse transcriptase-polymerase chain reaction and immunogold cytochemistry. J Mol Endocrinol 16, 183–195.
8Sandgren, ME, Brönnegärd, M & DeLuca, HF (1991) Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun 181, 611–616.
9Thomas, PK (1999) Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions. Eur Neurol 41, 35–43.
10Pari, L & Latha, M (2005) Antidiabetic effect of Scoparia dulcis: effect on lipid peroxidation in streptozotocin diabetes. Gen Physiol Biophys 24, 13–26.
11Chiu, J, Khan, ZA, Farhangkhoee, H, et al. (2009) Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappa B. Nutrition 25, 964–972.
12Junod, A, Lambert, AE, Staufferacher, W, et al. (1969) Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 48, 2129–2139.
13Hohenegger, M & Rudas, B (1971) Kidney function in experimental diabetic ketosis. Diabetologia 7, 334–338.
14de Souza Santos, R & Vianna, LM (2005) Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin Chim Acta 358, 146–150.
15Thomsen, WJ, Grottick, AJ, Menzaghi, F, et al. (2008) Lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325, 577–587.
16Hargreaves, BA, Barrales, LV, Barrales, DZ, et al. (2009) Glycogen determination in bovine muscle: a proposal for rapid determination. Chin J Agric Res 69, 366–372.
17Rajasekaran, S, Sivagnanam, K & Subramanian, S (2005) Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 57, 90–96.
18Satho, K (1978) Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta 90, 37–43.
19Crane, RK & Mandelstam, P (1960) The active transport of sugars by various preparations of hamster intestine. Biochim Biophys Acta 45, 460–476.
20Seglen, PO (1973) Preparation of rat liver cells II. Effects of ions and chelators on tissue dispersion. Exp Cell Res 76, 25–30.
21Jonshon, D & Lardy, H (1947) Isolation of liver kidney mitochondria. In Methods in Enzymology, pp. 94–96 [, editor]. London: Academic Press.
22Prokhorova, MI (1982) Methods of biochemical studies. Leningrad 45, 177–178.
23Lowry, OH, Rosenbrough, NH, Farr, AL, et al. (1951) Protein measurement with folin phenol reagent. J Biol Chem 193, 265–275.
24Mehler, AH, Kornberg, A, Grisolia, S, et al. (1948) Enzymic mechanism of oxidation–reductions between malate or isocitrate and pyruvate. J Biol Chem 174, 961–977.
25Chomczynski, P & Sacchi, N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162, 156–159.
26Rocco, MD, Calevo, MG, Taro', M, et al. (2008) Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Genet Metab 93, 398–402.
27Farrell, GC & Larter, CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99–S112.
28Gallán, PM, Carrascosa, A, Gussinyé, M, et al. (2003) Biomarkers of diabetes associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 34, 1563–1574.
29Gherzia, R, Andraghettia, G, Ferrannini, E, et al. (1986) Insulin receptor autophosphorylation and kinase activity in streptozotocin diabetic rats. Effect of a short fast. Biochem Biophys Res Commun 140, 850–856.
30Calle, C, Maestro, B & García-Arencibia, M (2008) Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol 9, 65.
31Caro, JF, Sinha, MK, Raju, SM, et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79, 1330–1337.
32Foti, D, Chiefari, E, Fedele, M, et al. (2005) Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 11, 765–773.
33Taylor, SI, Accili, D & Imai, Y (1994) Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43, 735–740.
34Maestro, B, Dávila, N, Carranza, MC, et al. (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84, 223–230.
35Kong, WJ, Zhang, H, Song, DQ, et al. (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58, 109–119.
36Zhang, H, Wei, J, Xue, R, et al. (2010) Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59, 285–292.
37Selberg, O, Burchert, W, Hoff, J, et al. (1993) Insulin resistance in liver cirrhosis. J Clin Invest 91, 1897–1902.
38Imano, E, Kanda, T, Nakatani, Y, et al. (1999) Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol 31, 413–469.
39Leturque, A, Brot-Laroche, E & Le Gall, M (2009) GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab 296, E985–E992.
40Rencurel, F, Waeber, G, Antoine, B, et al. (1996) Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver. Biochem J 314, 903–909.
41Schuit, F, Flamez, D, Vos, AD, et al. (2002) Glucose-regulated gene expression maintaining the glucose-responsive state of β-cells. Diabetes 51, S326–S332.
42Peterson, KF, Laurent, D, Rothma, DL, et al. (1998) Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101, 1203–1209.
43Weinstein, DA, Correia, CE, Saunders, AC, et al. (2006) Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia. Mol Genet Metab 87, 284–288.
44Féry, F, Plat, L, Melot, C, et al. (1996) Role of fat-derived substrates in the regulation of gluconeogenesis during fasting. Am J Physiol 270, E822–E830.
45Tomihira, M, Kawasaki, E, Nakajima, H, et al. (2004) Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL). Diabetes Res Clin Pract 65, 175–182.
46Jiang, W, Miyamoto, T, Kakizawa, T, et al. (2006) Inhibition of LXRa signaling by vitamin D receptor: possible role of VDR in bile acid synthesis. Biochem Biophys Res Commun 351, 176–184.
47Johna, W, Lafage-Proustb, MH, Massyc, ZA, et al. (2009) The prescription of vitamin D in dialysis patients in clinical practice guidelines for prescribing vitamin D in dialysis patients. Nephrol Ther 5, 520–532.
48National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039–1057.
49Masyuk, TV, Masyuk, AI, Torres, VE, et al. (2007) Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 132, 831–834.
50Chan, KY & Junger, D (1984) The effect of streptpzotocin-induced diabetes on the plasma membrane calcium uptake activity of rat liver. Diabetes 33, l072–1077.
51Smoake, JA & Solomon, SS (1980) Subcellular shifts in cyclic AMP phosphodiesterase and its calcium-dependent regulator in liver: role of diabetes. Biochem Biophys Res Commun 94, 424–430.
52Del Pino-Montes, J, Benito, GE, Fernández-Salazar, MP, et al. (2004) Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int 75, 526–532.
53Gerassimou, C, Kotanidou, A, Zhou, Z, et al. (2007) Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Br J Pharmacol 150, 1084–1091.
54Calafell, R, Boada, J, Santidrian, AF, et al. (2009) Fructose 1,6-bisphosphate reduced TNF-α-induced apoptosis in galactosamine sensitized rat hepatocytes through activation of nitric oxide and cGMP production. Eur J Pharmacol 610, 128–133.
55Sathishsekar, D & Subramanian, S (2005) Antioxidant properties of Momordica Charantia (bitter gourd) seeds on streptozotocin induced diabetic rats. Asia Pac J Clin Nutr 14, 153–158.
56Lehotsky, J, Kaplan, P, Racay, P, et al. (1999) Membrane ion transport system during oxidative stress in rodent brain: protective effect of ST and other antioxidants. Life Sci 65, 1951–1958.
57Kundsen, P, Ericksson, J, Lahdenpera, S, et al. (1995) Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. Diabetologia 38, 344–350.
58Ravi, K, Ramachandran, B & Subramanian, S (2004) Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol Pharm Bull 27, 1212–1217.
59Selvam, R & Anuradha, CV (1990) Effect of oral methionine on tissue lipid peroxidation and antioxidants in alloxan-induced diabetic rats. J Nutr Biochem 1, 653–658.